Altered Cytokine Production in Mice Lacking P2X7Receptors*

The P2X7 receptor (P2X7R) is an ATP-gated ion channel expressed by monocytes and macrophages. To directly address the role of this receptor in interleukin (IL)-1β post-translational processing, we have generated a P2X7R-deficient mouse line.P2X7R −/− macrophages respond to lipopolysaccharide and produce levels of cyclooxygenase-2 and pro-IL-1β comparable with those generated by wild-type cells. In response to ATP, however, pro-IL-1β produced by theP2X7R −/− cells is not externalized or activated by caspase-1. Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1β fromP2X7R −/− macrophages. In response to in vivo lipopolysaccharide injection, both wild-type andP2X7R −/− animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1. Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to additional IL-6 production; similar increases did not occur in ATP-treated, LPS-primedP2X7R −/− animals. Absence of the P2X7R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP. As a result of the IL-1 deficiency,in vivo cytokine signaling cascades are impaired in P2X7R-deficient animals. Together these results demonstrate that P2X7R activation can provide a signal that leads to maturation and release of IL-1β and initiation of a cytokine cascade.

[1]  D. Ferrari,et al.  Spontaneous Cell Fusion in Macrophage Cultures Expressing High Levels of the P2Z/P2X7 Receptor , 1997, The Journal of cell biology.

[2]  C. Gabel,et al.  Human monocyte stimulus-coupled IL-1β posttranslational processing: modulation via monovalent cations. , 1998, American journal of physiology. Cell physiology.

[3]  I. Schieren,et al.  P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. , 1994, Blood.

[4]  G. Dubyak,et al.  Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. , 1998, Molecular pharmacology.

[5]  L. Spain,et al.  Differential expression and regulation of cyclooxygenase isozymes in thymic stromal cells. , 1999, Journal of immunology.

[6]  B Henderson,et al.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Goeddel,et al.  Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta. , 1986, Journal of immunology.

[8]  C. Gargett,et al.  ATP, a partial agonist for the P2Z receptor of human lymphocytes , 1997, British journal of pharmacology.

[9]  K. Prickett,et al.  The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. , 1987, The Journal of biological chemistry.

[10]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[11]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[12]  C. Gabel,et al.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. , 1994, The Journal of biological chemistry.

[13]  C. Gabel,et al.  Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing. , 1996, Journal of immunology.

[14]  C. Gabel,et al.  IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. , 1992, Journal of immunology.

[15]  S. Bhakdi,et al.  Potassium‐inhibited processing of IL‐1 beta in human monocytes. , 1995, The EMBO journal.

[16]  G. Dubyak,et al.  Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. , 1996, Journal of immunology.

[17]  F. Di Virgilio,et al.  Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. , 1988, The Journal of biological chemistry.

[18]  Melanie Allen,et al.  Deficiency of the Stress Kinase P38α Results in Embryonic Lethality , 2000, The Journal of Experimental Medicine.

[19]  T. Steinberg,et al.  Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Kendrick,et al.  ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. , 1997, Immunity.

[21]  R. North,et al.  Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor , 1999, The Journal of physiology.

[22]  A Rubartelli,et al.  Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.

[23]  C. Gabay,et al.  Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.

[24]  C. Gabel,et al.  ATP Treatment of Human Monocytes Promotes Caspase-1 Maturation and Externalization* , 1999, The Journal of Biological Chemistry.

[25]  G. Dubyak,et al.  Maitotoxin and P2Z/P2X7purinergic receptor stimulation activate a common cytolytic pore. , 1999, American journal of physiology. Cell physiology.

[26]  Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. , 1989 .

[27]  I. Friedberg,et al.  Cellular responses to external ATP which precede an increase in nucleotide permeability in transformed cells , 1984, Journal of cellular physiology.

[28]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[29]  A. C. Webb,et al.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[31]  P. Walter,et al.  Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. , 1994, Annual review of cell biology.

[32]  G. Dubyak,et al.  Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. , 1993, The American journal of physiology.

[33]  I. Chessell,et al.  Blockade of human P2X7 receptor function with a monoclonal antibody , 1998 .

[34]  D. Ferrari,et al.  Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA) , 1997, The Journal of cell biology.

[35]  T. Yamin,et al.  Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells. , 1993, The Journal of biological chemistry.

[36]  C. March,et al.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs , 1985, Nature.

[37]  R. North,et al.  Families of ion channels with two hydrophobic segments. , 1996, Current Opinion in Cell Biology.

[38]  M. Balboa,et al.  Regulation of Arachidonic Acid Mobilization in Lipopolysaccharide-activated P388D1 Macrophages by Adenosine Triphosphate* , 1999, The Journal of Biological Chemistry.

[39]  S. Dower,et al.  Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors. , 1993, The Journal of biological chemistry.

[40]  I. Otterness,et al.  ATP induces the release of IL-1 from LPS-primed cells in vivo. , 1995, Journal of immunology.

[41]  M. Monk,et al.  HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.

[42]  I. Singer,et al.  Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes , 1988, The Journal of experimental medicine.

[43]  D. Ferrari,et al.  P2X7/P2Z Purinoreceptor-mediated Activation of Transcription Factor NFAT in Microglial Cells* , 1999, The Journal of Biological Chemistry.

[44]  Caterina Virginio,et al.  The Permeabilizing ATP Receptor, P2X7 , 1997, The Journal of Biological Chemistry.

[45]  F. Virgilio,et al.  Kinetics and Mechanism of ATP-Dependent IL-1β Release from Microglial Cells1 , 2000, The Journal of Immunology.

[46]  F. Di Virgilio,et al.  Mechanism of human sperm activation by extracellular ATP. , 1996, The American journal of physiology.

[47]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[48]  Douglas K. Miller,et al.  IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. , 1994, Journal of immunology.

[49]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[50]  A. Morrison,et al.  Interleukin-1β-induced Cyclooxygenase-2 Expression Requires Activation of Both c-Jun NH2-terminal Kinase and p38 MAPK Signal Pathways in Rat Renal Mesangial Cells* , 1998, The Journal of Biological Chemistry.

[51]  F. Di Virgilio,et al.  Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.

[52]  J. Swanson,et al.  ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. , 1987, The Journal of biological chemistry.

[53]  S. Bhakdi,et al.  Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. , 1990, The Journal of clinical investigation.

[54]  F. Di Virgilio,et al.  Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. , 1999, Journal of immunology.

[55]  R. Dolle,et al.  Inhibition of mature IL-1 beta production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 beta converting enzyme. , 1995, Journal of immunology.

[56]  E. Unanue,et al.  Interleukin 1 is processed and released during apoptosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  C. Little,et al.  Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[58]  E. Kawashima,et al.  Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.

[59]  E. Barnard,et al.  Cloning and functional characterisation of the mouse P2X7 receptor , 1998, FEBS letters.

[60]  I. Chessell,et al.  Identification and characterization of an endogenous P2X7 (P2Z) receptor in CHO‐K1 cells , 1998, British journal of pharmacology.

[61]  C. Gabel,et al.  Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages. , 1994, Journal of immunology.

[62]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[63]  F. Virgilio The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death , 1995 .

[64]  D. Ferrari,et al.  P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death , 1999, FEBS letters.

[65]  F. Di Virgilio,et al.  Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages. , 1992, The Biochemical journal.